Novel methods for the treatment and/or prophylaxis of diseases caused by tissue-adhering bacteria are disclosed. By interacting with periplasmic molecular chaperones it is achieved that the assembly of pili is prevented or inhibited and thereby the infectivity of the bacteria is diminished. Also disclosed are methods for screening for drugs as well as methods for the de novo design of such drugs, methods which rely on novel computer drug modelling methods involving an approximative calculation of binding free energy between macromolecules. Finally, novel pyranosides which are believed to be capable of interacting with periplasmic molecular chaperones are also disclosed.

 
Web www.patentalert.com

< Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes

< Diagnostic method for a transmissible spongiform encephalopathy or a prion disease

> Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug

> Oral pharmaceutical products containing 17 -estradiol-3-lower alkanoate, method of administering the same and process of preparation

~ 00219